ERK1/2 mediates NF-κB activation through a mechanism involving MAPK/p90RSK/IκBα signaling [38]; similarly, we demonstrated that this pathway was required for ILK-mediated NF-κB activation in gastric cancer cells. The gene discussed is NFKB1; the disease is gastric cancer.